Tobacco Products Scientific Advisory Committee (TPSAC) meeting 3-1-2012

On March 1st, 2012, the Tobacco Products Scientific Advisory Committee met to finalize their report on dissolvable tobacco products, and their impact in several areas including public health and on children’s health.

Background:  The TPSAC is an advisory panel within the FDA that was created by the Family Smoking Prevention and Tobacco Control Act (Public Law 111-31, signed by the President on June 22nd, 2009).  It consists of 12 members drawn from recognized experts in research and health care, as well as industry representatives.  It meets several times per year and commenced in 2010.  Its charter is to provide advisory information and recommendations concerning tobacco to the FDA and Health and Human Services (HHS).

This meeting was the culmination of several previous meetings (July 2011 and January 2012), and they are responding to the mandate to provide a report on dissolvable tobacco products by the Tobacco Control Act.  This report was submitted on March 23, 2012.

Specifically, they were tasked to address:

  • The risks and benefits of dissolvable tobacco products (DTP) to the population as a whole, including both users and non-users of tobacco products.
  • The likelihood (either increased or decreased) that current tobacco users will stop using tobacco and shift to (or not) DTP
  • The likelihood (either increased or decreased) that non-users will start using tobacco products.

We will update this post when the final report becomes available.  In the meantime, more information is available on the FDA website:  http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/
TobaccoProductsScientificAdvisoryCommittee/ucm294183.htm